Biochemical Markers as Predictors of Bone Mineral Density Changes After GnRH Agonist Treatment
β Scribed by D. Borderie; B. Cherruau; M. Dougados; O. G. Ekindjian; C. Roux
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 147 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Earlier osteodensitometric results of femoral periprosthetic bone showed that postoperative antiresorptive treatment with alendronate following total hip arthroplasty (THA) reduces the periprosthetic bone loss that commonly occurs in the first months after surgery. However, whether alen
## Abstract ## Objective To investigate the longitudinal changes both in the urinary concentrations of biochemical markers and in bone mineral density (BMD) during disease progression in the STR/Ort mouse model of osteoarthritis (OA). ## Methods Male STR/Ort mice were studied, with CBA mice used